- Home
- CDXS vs TGE Comparison
CDXS vs TGE Comparison
Compare CDXS & TGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDXS
- TGE
- Stock Information
- Founded
- CDXS 2002
- TGE 2023
- Country
- CDXS United States
- TGE France
- Employees
- CDXS N/A
- TGE N/A
- Industry
- CDXS Major Chemicals
- TGE Newspapers/Magazines
- Sector
- CDXS Industrials
- TGE Consumer Discretionary
- Exchange
- CDXS Nasdaq
- TGE Nasdaq
- Market Cap
- CDXS 254.3M
- TGE 290.8M
- IPO Year
- CDXS 2010
- TGE N/A
- Fundamental
- Price
- CDXS $2.69
- TGE $5.29
- Analyst Decision
- CDXS Buy
- TGE
- Analyst Count
- CDXS 2
- TGE 0
- Target Price
- CDXS $11.00
- TGE N/A
- AVG Volume (30 Days)
- CDXS 819.6K
- TGE 58.2K
- Earning Date
- CDXS 08-11-2025
- TGE 01-01-0001
- Dividend Yield
- CDXS N/A
- TGE N/A
- EPS Growth
- CDXS N/A
- TGE N/A
- EPS
- CDXS N/A
- TGE 1.64
- Revenue
- CDXS $49,815,000.00
- TGE $77,014,000.00
- Revenue This Year
- CDXS $12.53
- TGE N/A
- Revenue Next Year
- CDXS $22.54
- TGE N/A
- P/E Ratio
- CDXS N/A
- TGE $3.23
- Revenue Growth
- CDXS N/A
- TGE 81.03
- 52 Week Low
- CDXS $1.90
- TGE $5.23
- 52 Week High
- CDXS $6.08
- TGE $37.02
- Technical
- Relative Strength Index (RSI)
- CDXS 45.92
- TGE N/A
- Support Level
- CDXS $2.77
- TGE N/A
- Resistance Level
- CDXS $3.39
- TGE N/A
- Average True Range (ATR)
- CDXS 0.19
- TGE 0.00
- MACD
- CDXS -0.06
- TGE 0.00
- Stochastic Oscillator
- CDXS 13.58
- TGE 0.00
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
About TGE The Generation Essentials Group Class A Ordinary Shares
The Generation Essentials Group is a media and entertainment company. Its publications L'Officiel and The Art Newspaper publish print editions in a total of nearly 28 countries and territories and digital contents. It operate in the movie production sector having produced various Asia-focused movies. It operate in three operating segments: media and entertainment segment, hotel operations, hospitality and VIP services segment and strategic investment segment. Key revenue is generated from strategic investment segment that is engage in proprietary investments and management of portfolio, including listed and unlisted equity shares investments and movie income right investments.